Copyright
©The Author(s) 2023.
World J Clin Cases. Jun 16, 2023; 11(17): 4026-4034
Published online Jun 16, 2023. doi: 10.12998/wjcc.v11.i17.4026
Published online Jun 16, 2023. doi: 10.12998/wjcc.v11.i17.4026
Table 4 Baseline characteristics of patients with carbapenem-resistant Pseudomonas aeruginosa bloodstream infection
| Clinical variables | Patients (n = 57) |
| Age (yr) | 58 ± 23 |
| Length of hospital stay before infection (d) | 24 ± 5 |
| Combeites | |
| Blood system disease | 12 |
| Solid tumor | 11 |
| Admission to intensive care unit | 36 |
| APACHE II | 19 ± 7 |
| TTP | 18 ± 6 |
| Albumin < 30 g/L | 23 |
| Underwent surgery | 18 |
| Invasive mechanical ventilation | 12 |
| Antibiotic application ≥ 7 d | 37 |
| Outcome | |
| Sepsis and shock | 22 |
| Death | 17 |
- Citation: Jin LM, Shen H, Che XY, Jin Y, Yuan CM, Zhang NH. Anti-bacterial mechanism of baicalin-tobramycin combination on carbapenem-resistant Pseudomonas aeruginosa. World J Clin Cases 2023; 11(17): 4026-4034
- URL: https://www.wjgnet.com/2307-8960/full/v11/i17/4026.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i17.4026